Work

Abstract 3694: Clinical validation of a quantitative systems pharmacology (QSP) model of ISB 2001 used for deriving first in human (FIH) dose and efficient phase 1 dose escalation design in relapsed refractory multiple myeloma (RRMM) patients

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-3694

Authors: Vinu Menon, Beata Holkova, Lida Pacaud, Sunitha GN, Andrew Garton, Maria Pihlgren, Tomomi Matsuura, Piet H. van der Graaf, Mario Perro, Cyril Konto

Institutions: Ichnos Sciences (United States), Glenmark Pharmaceuticals (India)

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409631471

Cites:

Cited by: 2

Related to: 10